Main Menu

Myeloma Molecular Therapy Team

Dr Martin Kaiser’s Team aims to design gentler, tailored therapies for patients with multiple myeloma, an immune cell cancer of the bone marrow. 

Team leader

Dr Martin Kaiser

Dr Martin Kaiser

Team Leader

Dr Martin Kaiser is the team leader of the Myeloma Molecular Therapy group at the ICR and an honorary consultant in Haematology at The Royal Marsden NHS Foundation Trust.

ORCID 0000-0002-3677-4804

Team members

Nikita Cray
Nikita Cray
Scientific Officer +44 20 3437 6576

I joined the Myeloma Group in June 2021 and process blood and bone marrow samples from national myeloma clinical trials. Using a variety of molecular biology techniques, I generate data to assess molecular profiles and genetic aberrations in myeloma patients.

Isabel Nichols
Isabel Nichols
Scientific Officer

I joined the team in December 2020 and I am involved in the bio-banking of samples from national myeloma clinical trials. I use flow cytometry and a variety of molecular biology techniques to assess molecular profiles and genetic aberrations in patients with multiple myeloma.

Dr Katerina Panopoulou
Clinical Research Fellow T +44 20 8722 4659